Essential Prescribing Information

The Spanner™ Prostatic Stent Brief Disclosure

Indications: The Spanner™ Temporary Prostatic Stent is intended for temporary use (up to 30 days) to maintain urine flow and allow voluntary urination in patients following minimally invasive treatment for benign prostatic hyperplasia (BPH) and after initial post-treatment catheterization.

Potential Adverse Events: Side effects may include urinary retention, urinary incontinence, hematuria, perineal pain, and migration. For a more complete listing of adverse events, please refer to the Physician's IFU for The Spanner and Surveyor.

Caution: Federal law restricts this device to sale by or on the order of a physician. For a listing of indications, contraindications, precautions, and adverse events, please refer to the Physician's IFU for The Spanner and Surveyor.